Lefkowitz Steven W 4

4 · CorMedix Inc. · Filed Feb 23, 2022

Form 4

Period: 2022-02-22

Director

Transactions

Award
Stock Option (Right to Buy Common Stock)
2022-02-22+20,000→ 20,000 total
Exercise: $4.03Exp: 2032-02-22→ Common Stock (20,000 underlying)

Holdings

Common Stock
(indirect: By Spouse)
2,000
Common Stock
60,498
Stock Option (Right to Buy Common Stock)
Exercise: $2.85Exp: 2028-02-16→ Common Stock (8,000 underlying)
8,000
Stock Option (Right to Buy Common Stock)
Exercise: $5.63Exp: 2030-02-25→ Common Stock (15,000 underlying)
15,000
Common Stock
(indirect: Wade Capital Corp Money Purchase Plan)
30,152
Stock Option (Right to Buy Common Stock)
Exercise: $8.32Exp: 2031-01-11→ Common Stock (30,000 underlying)
30,000
Stock Option (Right to Buy Common Stock)
Exercise: $8.30Exp: 2029-01-10→ Common Stock (15,000 underlying)
15,000
Stock Option (Right to Buy Common Stock)
Exercise: $2.25Exp: 2027-06-25→ Common Stock (15,000 underlying)
15,000

Footnotes (7)

[F1]The reporting person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which he has voting and investment control).
[F2]These options were granted on 1/11/2021. These options are fully vested.
[F3]These options were granted on 02/25/2020. These options are fully vested.
[F4]These options were granted on 01/10/2019. The options are fully vested.
[F5]These options were granted on 2/16/2018. These options are fully vested.
[F6]These options were granted on 6/25/2017. These options are fully vested.
[F7]These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

Documents

1 file